CIDEB and CGI-58 Regulate Liver Lipid Droplet Size with Cholesterol Content, Linking to Inflammation and Fibrosis in Metabolic Dysfunction-Associated Steatohepatitis

被引:0
|
作者
Sakuma, Ikki
Gaspar, Rafael C.
Nasiri, Ali
Kahn, Mario
Zheng, Jie
Guerra, Mateus
Yimlamai, Dean
Murray, Sue
Perelis, Mark
Barnes, William
Vatner, Daniel F.
Petersen, Kitt
Samuel, Varman
Shulman, Gerald I.
机构
关键词
D O I
10.2337/db24-1571-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1571-P
引用
收藏
页数:2
相关论文
共 44 条
  • [21] Interleukin-11 signaling plays limited roles for liver fibrosis in a mouse model of metabolic dysfunction-associated steatohepatitis
    Tsuchiya, Yuichi
    Nishina, Takashi
    Komazawa-Sakon, Sachiko
    Seki, Takao
    Mikami, Tetuo
    Nakano, Hiroyasu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 739
  • [22] Effect of Pemafibrate on the Lipid Profile, Liver Function, and Liver Fibrosis Among Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
    Hassan, Mona
    Al-Obaidi, Hasan
    Karrick, Megan
    Merza, Nooraldin
    Nawras, Yusuf
    Saab, Omar
    Al-Obaidi, Ahmed Dheyaa
    Merza, Fatima
    Hashim, Hashim Talib
    Al Zubaidi, Khalid
    Al-Sabbagh, Daniah
    Matbachi, Rand
    Noori, Zainab
    Amatul-Raheem, Hajra
    Mansur, Sarmad
    Al Najafi, Omer
    Algodi, Marwah
    Al Hamdany, Tamarah
    Kobeissy, Abdallah
    GASTROENTEROLOGY RESEARCH, 2024, 17 (04) : 159 - 174
  • [23] FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis
    Martinez-Arenas, Laura
    Carvalho-Gomes, Angela
    Vinaixa, Carmen
    Conde, Isabel
    Perez-Rojas, Judith
    Montalva, Eva
    Lorente Perez, Sara
    Diaz Fontela, Fernando
    Guerrero-Misas, Marta
    Ignacio Herrero, Jose
    Berenguer, Marina
    JOURNAL OF HEPATOLOGY, 2024, 80 : S531 - S531
  • [24] FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis
    Martinez-Arenas, L.
    Carvalho-Gomes, A.
    Vinaixa, C.
    Conde, I.
    Perez-Rojas, J.
    Montalva, E.
    Lorente, S.
    Diaz-Fontenla, F.
    Guerrero-Misas, M.
    Herrero, I.
    Berenguer, M.
    LIVER TRANSPLANTATION, 2024, 30 : 150 - 151
  • [25] Enhancing the diagnosis of metabolic dysfunction-associated steatohepatitis with advanced liver fibrosis using FibroScan-aspartate aminotransferase (FAST) score
    Teh, Wei Ling
    Fiori, James
    Lam, Wendy
    Welman, Christopher
    Ayonrinde, Oyekoya
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 98 - 98
  • [26] Risk Factors, Clinical Presentation and Non-Invasive Liver Fibrosis Tests for Advanced Liver Fibrosis in Biopsy Diagnosed Metabolic Dysfunction-Associated Steatotic Liver Disease or Steatohepatitis
    Lau, Hien
    Samarasena, Jason
    Hu, Ke-Qin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1277 - S1278
  • [27] Prevent and Reverse Metabolic Dysfunction-Associated Steatohepatitis and Hepatic Fibrosis via mRNA-Mediated Liver-Specific Antibody Therapy
    Zhang, Chenshuang
    Teng, Yilong
    Bai, Xin
    Tang, Maoping
    Stewart, William
    Chen, Jake Jinkun
    Xu, Xiaoyang
    Zhang, Xue-Qing
    ACS NANO, 2024, 18 (50) : 34375 - 34390
  • [28] Unlocking the influence of PNPLA3 mutations on lipolysis: Insights into lipid droplet formation and metabolic dynamics in metabolic dysfunction-associated steatotic liver disease
    Roy, Alankar
    Paul, Ishani
    Chakraborty, Priyanka
    Saha, Adrija
    Ray, Sujay
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2025, 1869 (03):
  • [29] Cutting Edge: Hepatic Stellate Cells Drive the Phenotype of Monocyte-derived Macrophages to Regulate Liver Fibrosis in Metabolic Dysfunction-associated
    Chan, Mandy M.
    He, Li
    Finck, Brian N.
    Schilling, Joel D.
    Daemen, Sabine
    JOURNAL OF IMMUNOLOGY, 2024, 213 (03): : 251 - 256
  • [30] Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria
    Pennisi, Grazia
    Enea, Marco
    Romero-Gomez, Manuel
    Bugianesi, Elisabetta
    Wong, Vincent Wai-Sun
    Fracanzani, Anna Ludovica
    de Ledinghen, Victor
    George, Jacob
    Berzigotti, Annalisa
    Vigano, Mauro
    Sebastiani, Giada
    Cannella, Roberto
    Delamarre, Adele
    Di Maria, Gabriele
    Lange, Naomi F.
    Tulone, Adele
    Di Marco, Vito
    Camma, Calogero
    Petta, Salvatore
    HEPATOLOGY, 2024, 79 (04) : 912 - 925